FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...